Stylists Fear Hollywood Stars Blind to Extreme Thinness from Ozempic Microdosing

In the glitz of Hollywood's awards season, a concerning trend has emerged: celebrities like Emma Stone, Demi Moore, and Jenna Ortega appearing shockingly thin on red carpets at the Actor Awards and Golden Globes. This shift from curvaceous figures to fragile, pin-thin silhouettes has stylists and health experts alarmed. Actress Jameela Jamil, who has openly discussed her struggles with disordered eating, highlighted the issue on Instagram after the BAFTAs: "Everyone looks like they could snap. It's a specifically fragile type of thin."

The Rise of Microdosing Ozempic and GLP-1s in Hollywood

While the pursuit of thinness is a longstanding Hollywood staple—recall Kate Moss's infamous "Nothing tastes as good as skinny feels"—the current wave involves microdosing Ozempic and other GLP-1 receptor agonists. Multiple sources told Page Six that even already-thin stars are taking "baby" doses, smaller than the FDA-approved therapeutic starting dose of 0.25 ml injections for the first month, gradually increasing from there.

GLP-1 medications like Ozempic (semaglutide) were developed for type 2 diabetes and chronic weight management in obesity, mimicking the GLP-1 hormone to slow gastric emptying, reduce appetite, and promote satiety. At full therapeutic doses, they lead to 15-20% body weight loss when combined with diet and exercise. However, microdosing—using subtherapeutic amounts—aims for subtler effects but still suppresses hunger, potentially leading to insufficient calorie and nutrient intake without medical oversight.

"There's a stigma now to having any weight," one stylist and former Vogue editor told Page Six.

A top Hollywood dermatologist added: "My female clients ... have been microdosing GLP 1s for a long time now. Body positivity was over the minute GLPs started flooding the market. It costs less to microdose, it's more tolerable on your body -- and you still let yourself eat." Yet, as experts note, "not enough" eating is the problem.

Why Microdosing Poses Unique Risks

Microdosing GLP-1s bypasses proper protocols, increasing risks like nutrient deficiencies and muscle loss (sarcopenia). These drugs promote fat loss but can accelerate muscle breakdown if protein intake is low or resistance training absent. In clinical settings, GLP-1s require monitoring for lean mass preservation through high-protein diets (1.6-2.2g/kg body weight) and strength exercises.

Health Experts Warn of Malnutrition and Muscle Wasting

Celebrity nutritionist Jess Baker has observed alarming changes: "visible signs of muscle wasting in several celebrities where it wasn't present before -- hollowed temples, full clavicles showing, shoulder blades jutting out." She explains, "In a clinical setting, these changes from baseline are cause for alarm. They can indicate malnutrition, meaning the body isn't getting enough of what it needs to function."

Muscle wasting from rapid weight loss via GLP-1s or calorie restriction depletes vital reserves, raising risks for weakened immunity, fatigue, osteoporosis, and metabolic slowdown. Older adults face added dangers like sagging skin, as stylist Hoza Rodriguez notes: "If you're of a certain age, you have to worry about your skin. You're not a rubber band [that bounces back]."

Stylists' Dilemma: Dressing the 'Scarily Thin'

A-list stylists are in a bind. "You can't tell these actresses they're too skinny," one said. "They'll just say, but [another actress] is smaller than I am!" Peer pressure amplifies this: "One actress sees another one get smaller, then another goes even smaller."

To compensate, stylists layer jackets, shirts under strapless dresses, or coats. Showroom owners report size 2 samples needing major alterations: "We actually brought in some great tailors and cutters ... They mostly all had to be taken in this awards season."

Beyond GLP-1s: Surgical and Industry Pressures

The trend isn't solely drug-driven. "They're supplementing [weight loss] with face surgery," the former Vogue editor said. Even 20-somethings opt for buccal fat removal to hollow cheeks, as Chrissy Teigen has admitted, with Reddit speculation on others.

Industry incentives fuel it. Lucrative fashion and beauty brand deals favor thin frames: "When it comes to a brand deal -- [designers] are very selective. There's only so many types of Lizzos that people want to work with," Rodriguez said, noting Lizzo's 60-pound loss. Stylist Kate Young told Vanity Fair: "... The reality is that brands are who hold the purse strings right now." Fashion houses embrace the shift: "People are so tired of this woke s--t," Rodriguez claimed.

Safer Approaches to Weight Management with GLP-1s

For those considering GLP-1s like Ozempic or alternatives (e.g., Wegovy, Mounjaro), consult a physician for FDA-approved indications. Proper use includes:

• Gradual titration starting at 0.25 mg weekly
• High-protein diet to preserve muscle
• Resistance training 2-3x/week
• Monitoring via DEXA scans for body composition

Avoid microdosing without supervision—it risks disordered eating patterns. Tools like Shotlee can help track symptoms, side effects, or medication adherence safely.

Compared to alternatives like phentermine or bariatric surgery, GLP-1s offer cardiometabolic benefits but demand lifestyle integration to avoid muscle waste.

Key Takeaways: What This Means for Health and Hollywood

• Hollywood's super-skinny trend via Ozempic microdosing risks malnutrition and muscle wasting.
• Stylists and experts urge awareness: thinness chases breed dissatisfaction—"Once you are thin, the chase doesn't stop."
• Prioritize health: Discuss GLP-1s with doctors for obesity/diabetes, not aesthetics.
• Signs like hollow temples signal intervention needs.

Conclusion: Balancing Red Carpet Glamour and Health

Hollywood's thin ideal pressures stars into risky practices, blurring health lines. As the former Vogue editor warns: "In fashion and Hollywood, you're always chasing... it breeds an environment of never being enough." Sustainable metabolic health trumps fleeting trends—seek professional guidance for GLP-1 therapy to protect muscle and vitality.